225 related articles for article (PubMed ID: 35069702)
1. Landscape Analysis of Matrix Metalloproteinases Unveils Key Prognostic Markers for Patients With Breast Cancer.
Cheng T; Chen P; Chen J; Deng Y; Huang C
Front Genet; 2021; 12():809600. PubMed ID: 35069702
[TBL] [Abstract][Full Text] [Related]
2. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Analysis of the Expression and Prognosis for MMPs in Human Colorectal Cancer.
Yu J; He Z; He X; Luo Z; Lian L; Wu B; Lan P; Chen H
Front Oncol; 2021; 11():771099. PubMed ID: 34804973
[TBL] [Abstract][Full Text] [Related]
4. A pan-cancer perspective of matrix metalloproteases (MMP) gene expression profile and their diagnostic/prognostic potential.
Gobin E; Bagwell K; Wagner J; Mysona D; Sandirasegarane S; Smith N; Bai S; Sharma A; Schleifer R; She JX
BMC Cancer; 2019 Jun; 19(1):581. PubMed ID: 31200666
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 1 is a poor prognostic biomarker for patients with hepatocellular carcinoma.
Xu L; Yang H; Yan M; Li W
Clin Exp Med; 2023 Oct; 23(6):2065-2083. PubMed ID: 36169759
[TBL] [Abstract][Full Text] [Related]
6. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma.
Wang T; Zhang Y; Bai J; Xue Y; Peng Q
BMC Cancer; 2021 Sep; 21(1):1068. PubMed ID: 34587931
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer.
Luan H; Jian L; Huang Y; Guo Y; Zhou L
Sci Rep; 2023 Oct; 13(1):17211. PubMed ID: 37821678
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms.
Jackson V; Olsson T; Kurtovic S; Folkersen L; Paloschi V; Wågsäter D; Franco-Cereceda A; Eriksson P
J Thorac Cardiovasc Surg; 2012 Aug; 144(2):459-66. PubMed ID: 21955474
[TBL] [Abstract][Full Text] [Related]
9. Mining the prognostic significance and immune infiltration of
Zhou Y; Jiang S; Yu S; Zhu L; Liu Y; Li S; Hao N; Ren Y
Gland Surg; 2022 Apr; 11(4):720-741. PubMed ID: 35531108
[TBL] [Abstract][Full Text] [Related]
10. Abnormal Hypermethylation of CpG Dinucleotides in Promoter Regions of Matrix Metalloproteinases Genes in Breast Cancer and Its Relation to Epigenomic Subtypes and HER2 Overexpression.
Simonova OA; Kuznetsova EB; Tanas AS; Rudenko VV; Poddubskaya EV; Kekeeva TV; Trotsenko ID; Larin SS; Kutsev SI; Zaletaev DV; Nemtsova MV; Strelnikov VV
Biomedicines; 2020 May; 8(5):. PubMed ID: 32397602
[TBL] [Abstract][Full Text] [Related]
11. New signaling pathways from cancer progression modulators to mRNA expression of matrix metalloproteinases in breast cancer cells.
Delassus GS; Cho H; Eliceiri GL
J Cell Physiol; 2011 Dec; 226(12):3378-84. PubMed ID: 21344390
[TBL] [Abstract][Full Text] [Related]
12. An integrated bioinformatics analysis of potential therapeutic targets among matrix metalloproteinases in breast cancer.
Xia H; Yu W; Liu M; Li H; Pang W; Wang L; Zhang Y
Oncol Lett; 2019 Sep; 18(3):2985-2994. PubMed ID: 31452777
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value and potential mechanism of Matrix Metalloproteinases among Prostate Cancer.
Geng X; Chen C; Huang Y; Hou J
Int J Med Sci; 2020; 17(11):1550-1560. PubMed ID: 32669958
[No Abstract] [Full Text] [Related]
14. Matrix metalloproteinases expression correlates with survival in patients with esophageal squamous cell carcinoma.
Gu ZD; Li JY; Li M; Gu J; Shi XT; Ke Y; Chen KN
Am J Gastroenterol; 2005 Aug; 100(8):1835-43. PubMed ID: 16086722
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential diagnostic biomarkers in MMPs for pancreatic carcinoma.
Xie J; Zhou X; Wang R; Zhao J; Tang J; Zhang Q; Du Y; Pang Y
Medicine (Baltimore); 2021 Jun; 100(23):e26135. PubMed ID: 34114996
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of MMPs in Corneas Requiring Penetrating and Deep Anterior Lamellar Keratoplasty.
Wolf M; Clay SM; Oldenburg CE; Rose-Nussbaumer J; Hwang DG; Chan MF
Invest Ophthalmol Vis Sci; 2019 Apr; 60(5):1734-1747. PubMed ID: 31022731
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases MMP1, MMP2, MMP9 and their tissue inhibitors TIMP1, TIMP2, TIMP3 in head and neck cancer: an immunohistochemical study.
Pietruszewska W; Bojanowska-Poźniak K; Kobos J
Otolaryngol Pol; 2016 Jun; 70(3):32-43. PubMed ID: 27386931
[TBL] [Abstract][Full Text] [Related]
18. NEFM DNA methylation correlates with immune infiltration and survival in breast cancer.
Li D; Zhao W; Zhang X; Lv H; Li C; Sun L
Clin Epigenetics; 2021 May; 13(1):112. PubMed ID: 34001208
[TBL] [Abstract][Full Text] [Related]
19. A quantitative gene expression profile of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) in the myocardium of patients with deteriorating heart failure requiring left ventricular assist device support.
Felkin LE; Birks EJ; George R; Wong S; Khaghani A; Yacoub MH; Barton PJ
J Heart Lung Transplant; 2006 Dec; 25(12):1413-9. PubMed ID: 17178334
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting KLRB1 expression is associated with impairing cancer immunity and leading to cancer progression and poor prognosis in breast invasive carcinoma patients.
He JR; Li D; Zhang QX; Liu T; Ding Y; Wu CY; Chen SS; Chen JL
Aging (Albany NY); 2023 Nov; 15(22):13265-13286. PubMed ID: 37988189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
